LAURA WAY: Open Payments
NPI 1366131401 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,265 in 69 payments from 17 companies in 2025. Trend: 2023 $679 · 2024 $1,695 · 2025 $1,265
Food & beverage: $1,265
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $307 |
| Lundbeck LLC | 6 | $151 |
| Otsuka America Pharmaceutical, Inc. | 12 | $148 |
| Almatica Pharma LLC | 8 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| ABBVIE INC. | 5 | $81 |
| Teva Pharmaceuticals USA, Inc. | 4 | $80 |
| Neurocrine BioSciences, Inc. | 2 | $50 |
| Alkermes, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
Products named: FANAPT, REXULTI, LOREEV XR, CAPLYTA, VRAYLAR, AUSTEDO XR, INGREZZA, LYBALVI.
Industry payments across GA — which companies pay providers there.
